Mirae Asset Global Investments Co., Ltd. Charles River Laboratories International, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,301 shares of CRL stock, worth $864,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,301
Previous 3,622
46.36%
Holding current value
$864,699
Previous $713,000
37.17%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
51.7MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$995 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$830 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$610 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$347 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$316 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...